Table 3.
Study | Type of Study | No of Patients | No of ART Cycles | Relapses with GnRH Agonists | Relapses with GnRH Antagonists | Reference |
---|---|---|---|---|---|---|
Laplaud et al., 2006 | Retrospective | 6 | 10 | 5/6 treatments | 0/4 treatments | [130] |
Hellwig et al., 2008 | Retrospective | 6 | 14 | 3/9 treatments | 2/5 treatments | [131] |
Hellwig et al., 2009 | Prospective/retrospective | 23 | 78 | Increased annualized relapse rate (ARR) | Increased ARR | [132] |
Hellwig et al., 2009 | Prospective group | 10 | 14 | 2/8 | 1/4 | [132] |
Correale et al., 2012 | Prospective | 16 | 26 | 15/26 | Not applicable | [133] |
Michel et al., 2012 | Retrospective | 32 | 70 | Increased ARR (48 treatments) | No increased ARR (19 treatments) | [134] |